FDA Approves New Cyanokit Presentation

Merck Serono SA April 29 announced that a new presentation of Cyanokit 5 grams (hydroxocobalamin) has been approved by the Food and Drug Administration.

In the United States, Cyanokit is available in a kit comprising two 2.5-gram vials as the starting dose that totals 5 grams hydroxocobalamin, the Geneva, Switzerland-based company said. The new presentation contains the initial antidote dose of 5 grams hydroxocobalamin in a single vial.

Cyanokit is indicated for treating known or suspected cyanide poisoning, Merck Serono said. In the United States, Cyanokit is commercialized through Merck Serono’s partner Meridian Medical Technologies Inc., which belongs to Pfizer ...